Interestingly, in the Pahenu2 mouse model of PKU, which is characterized by high levels of plasma Phe, homozygous loss of Slc6a19 causes increased urinary excretion of amino acids including Phe as well as an approximately 70% decrease in plasma Phe (14). Here, SLC6A19 is linked to phenylketonuria.